Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Interest Coverage Ratio (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Interest Coverage Ratio for 4 consecutive years, with 2358.33 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 160.3% to 2358.33 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1753.94 through Dec 2025, down 95.61% year-over-year, with the annual reading at 1753.94 for FY2025, 95.61% down from the prior year.
  • Interest Coverage Ratio hit 2358.33 in Q4 2025 for Taysha Gene Therapies, down from 2268.27 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 11.05 in Q3 2023 to a low of 6206.38 in Q1 2022.
  • Historically, Interest Coverage Ratio has averaged 1082.44 across 4 years, with a median of 813.91 in 2024.
  • Biggest five-year swings in Interest Coverage Ratio: skyrocketed 99.81% in 2023 and later tumbled 9668.19% in 2024.
  • Year by year, Interest Coverage Ratio stood at 41.35 in 2022, then skyrocketed by 44.9% to 22.79 in 2023, then tumbled by 3876.23% to 906.0 in 2024, then plummeted by 160.3% to 2358.33 in 2025.
  • Business Quant data shows Interest Coverage Ratio for TSHA at 2358.33 in Q4 2025, 2268.27 in Q3 2025, and 1573.71 in Q2 2025.